Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending August 10, 2024 (Week 32)
Reporting Area Chlamydia trachomatis infection §
Current weekPrevious 52 weeks Max †Cum YTD 2024 †Cum YTD 2023 †
U.S. Residents, excluding U.S. Territories 12,995 35,194 826,029 1,028,740
New England 170 1,172 20,440 33,209
Connecticut - 318 - 8,057
Maine 51 81 1,622 1,813
Massachusetts - 647 14,049 17,726
New Hampshire 39 76 1,402 1,732
Rhode Island 80 389 2,594 3,033
Vermont - 33 773 848
Middle Atlantic 1,762 4,379 110,225 123,146
New Jersey 448 788 18,518 22,207
New York (excluding New York City) - 957 23,112 25,923
New York City 637 1,565 36,922 41,278
Pennsylvania 677 1,168 31,673 33,738
East North Central 1,591 4,704 97,706 141,121
Illinois - 1,497 17,212 43,553
Indiana 380 698 18,661 21,456
Michigan 198 1,020 17,575 26,185
Ohio 632 1,153 30,009 34,454
Wisconsin 381 533 14,249 15,473
West North Central 837 2,118 53,951 60,224
Iowa 116 313 7,218 8,515
Kansas 113 304 7,287 8,366
Minnesota 105 486 12,003 13,499
Missouri 459 724 18,269 19,010
Nebraska - 225 4,823 5,651
North Dakota 43 87 1,859 2,129
South Dakota 1 118 2,492 3,054
South Atlantic 3,003 12,279 207,280 236,398
Delaware - 227 3,031 3,483
District of Columbia 77 191 4,091 5,248
Florida 1,526 6,935 67,307 69,741
Georgia - 1,501 38,955 45,769
Maryland - 1,016 16,375 21,944
North Carolina 5 1,434 31,419 41,210
South Carolina 569 820 20,194 20,570
Virginia 806 934 23,392 25,738
West Virginia 20 116 2,516 2,695
East South Central 988 2,748 37,036 67,684
Alabama 554 894 19,719 20,960
Kentucky 342 592 9,657 9,960
Mississippi 92 1,006 7,660 12,678
Tennessee - 1,313 - 24,086
West South Central 648 4,708 114,901 140,860
Arkansas 169 398 9,767 11,362
Louisiana 382 799 20,227 22,686
Oklahoma 45 422 6,251 12,288
Texas 52 3,260 78,656 94,524
Mountain 1,158 2,691 59,560 71,823
Arizona 355 929 23,074 25,273
Colorado 483 857 13,298 16,016
Idaho 53 127 3,138 3,616
Montana 39 98 2,012 2,241
Nevada 16 357 6,556 9,685
New Mexico 16 256 4,423 6,978
Utah 178 255 6,175 6,848
Wyoming 18 47 884 1,166
Pacific 2,838 5,124 124,930 154,275
Alaska 72 125 3,018 3,197
California 2,146 3,947 102,762 120,083
Hawaii - 146 - 3,911
Oregon 268 382 8,510 9,488
Washington 352 609 10,640 17,596
U.S. Territories - 135 667 3,163
American Samoa - 0 - -
Commonwealth of Northern Mariana Islands - 0 - -
Guam - 0 - -
Puerto Rico - 135 667 3,163
U.S. Virgin Islands - 0 - -
Non-U.S. Residents 1 3 17 36
Total 12,996 35,238 826,713 1,031,939
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2023 and 2024 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2022, only confirmed cases are published to align with the approved CSTE position statement 21-ID-06, whereas in previous years, all case classification statuses were published. This change may cause a decrease in published case counts when compared to previous years.